PMPRB adopts Amended Interim Guidance pending release of new guidelines | Smart & Biggar : vimarsana.com

As previously reported, the Patented Medicine Prices Review Board (PMPRB) proposed amendments in June 2023 to its Interim Guidance (“Amended Interim Guidance”) for reviewing the prices...

Related Keywords

Canada , , Patented Medicine Prices Review Board , Interim Guidance , Patented Medicines , Amended Interim Guidance , Maximum Average Potential Price , Non Excessive Average Price , New Medicines , Interim Period ,